Mitochondrial Disorders pp 149-168

Part of the Methods in Molecular Biology book series (MIMB, volume 837)

Measurement of Oxidized and Reduced Coenzyme Q in Biological Fluids, Cells, and Tissues: An HPLC-EC Method



Direct measure of coenzyme Q (CoQ) in biological specimens may provide important advantages. Precise and selective high-performance liquid chromatography (HPLC) methods with electrochemical (EC) detection have been developed for the measurement of reduced (ubiquinol) and oxidized (ubiquinone) CoQ in biological fluids, cells, and tissues. EC detection is preferred for measurement of CoQ because of its high sensitivity. Reduced and oxidized CoQ are first extracted from biological specimens using 1-propanol. After centrifugation, the 1-propanol supernatant is directly injected into HPLC and monitored at a dual-electrode. The EC reactions occur at the electrode surface. The first electrode transforms ubiquinone into ubiquinol, and the second electrode measures the current produced by the oxidation of the hydroquinone group of ubiquinol. The methods described provide rapid, precise, and simple procedures for determination of reduced and oxidized CoQ in biological fluids, cells, and tissues. The methods have been successfully adapted to meet regulatory requirements for clinical laboratories, and have been proven reliable for analysis of clinical and research samples for clinical trials and animal studies involving large numbers of specimens.

Key words

Coenzyme Q Ubiquinol Ubiquinone Redox HPLC Coulometric Electrochemical Analysis Plasma Milk Platelet Muscle Liver Brain 


  1. 1.
    Turunen M., Olsson J., and Dallner G. (2004) Metabolism and function of coenzyme Q. Biochim Biophys Acta 1660, 171–199.PubMedCrossRefGoogle Scholar
  2. 2.
    Bentinger M., Tekle M., and Dallner G. (2010) Coenzyme Q-biosynthesis and functions. Biochem Biophys Res Commun. 21, 396, 74–79.CrossRefGoogle Scholar
  3. 3.
    Barshop B.A. and Gangoiti J.A. (2007) Analysis of coenzyme Q in human blood and tissues. Mitochondrion 7 Suppl, S89–93.PubMedCrossRefGoogle Scholar
  4. 4.
    Quinzii C.M., López L.C., Gilkerson R.W., et al. (2010) Reactive oxygen species, oxidative stress, and cell death correlate with level of CoQ10 deficiency. FASEB J. 24, 3733–3743.PubMedCrossRefGoogle Scholar
  5. 5.
    Rodríguez-Hernández A., Cordero M.D., Salviati L., et al. (2009) Coenzyme Q deficiency triggers mitochondria degradation by mitophagy. Autophagy. 5, 19–32.PubMedCrossRefGoogle Scholar
  6. 6.
    Miles L., Miles M.V., Tang P.H., et al. (2005) Coenzyme Q: a potential marker for mitochondrial activity and redox status in skeletal muscle. Pediatr Neurol 32, 318–324.PubMedCrossRefGoogle Scholar
  7. 7.
    Miles L., Wong B.L., Dinopoulos A., et al. (2006) Investigation of children for mitochondriopathy confirms need for strict patient selection, improved morphological criteria, and better laboratory methods. Hum Pathol 37, 173–184.PubMedCrossRefGoogle Scholar
  8. 8.
    Haas R.H., Parikh S., Falk M.J., et al. (2008) The in-depth evaluation of suspected mitochondrial disease. Mol Genet Metab 94, 16–37.PubMedCrossRefGoogle Scholar
  9. 9.
    Miles M.V., Miles L., Tang P.H., et al. (2008) Systematic evaluation of muscle coenzyme Q10 content in children with mitochondrial respiratory chain deficiencies. Mitochondrion 8, 170–180.PubMedCrossRefGoogle Scholar
  10. 10.
    Miles M.V., Putnam P.E., Miles L., et al. (2011) Acquired coenzyme Q10 deficiency in children with recurrent food intolerance and allergies. Mitochondrion 11, 127–135.PubMedCrossRefGoogle Scholar
  11. 11.
    Quinzii C.M. and Hirano M. (2010) Coenzyme Q and mitochondrial disease. Dev Disabil Res Rev 16, 183–188.PubMedCrossRefGoogle Scholar
  12. 12.
    Quinzii C.M., López L.C., Von-Moltke J., et al. (2008) Respiratory chain dysfunction and oxidative stress correlate with severity of primary CoQ10 deficiency. FASEB J 22, 1874–1885.PubMedCrossRefGoogle Scholar
  13. 13.
    Villalba J.M., Parrado C., Santos-Gonzalez M., et al. (2010) Therapeutic use of coenzyme Q10 and coenzyme Q10-related compounds and formulations. Expert Opin Investig Drugs 19, 535–554.PubMedCrossRefGoogle Scholar
  14. 14.
    Tang P.H., Miles M.V., DeGrauw A., et al. (2001) HPLC analysis of reduced and oxidized coenzyme Q10 in human plasma. Clin Chem 47, 256–265.PubMedGoogle Scholar
  15. 15.
    Miles M.V., Horn P., Morrison J.A., et al. (2003) Plasma coenzyme Q10 reference intervals, but not redox status, are affected by gender and race in self-reported healthy adults. Clin Chim Acta 332, 123–132.PubMedCrossRefGoogle Scholar
  16. 16.
    Miles M.V., Horn P.S., Tang P.H., et al. (2004) Age-related changes in plasma coenzyme Q10 concentrations and redox state in apparently healthy children and adults. Clin Chim Acta 347, 139–144.PubMedCrossRefGoogle Scholar
  17. 17.
    Niklowitz P., Andler W., and Menke T. (2006) Coenzyme Q10 concentration in plasma and blood cells: what about diurnal changes? Biofactors 28, 47–54.PubMedCrossRefGoogle Scholar
  18. 18.
    Miles M.V., Tang P.H., Miles L., et al. (2008) Validation and application of an HPLC-EC method for analysis of coenzyme Q10 in blood platelets. Biomed Chromatogr 22, 1403–1408.PubMedCrossRefGoogle Scholar
  19. 19.
    Tang P.H., Miles M.V., Miles L., et al. (2004) Measurement of reduced and oxidized coenzyme Q9 and coenzyme Q10 levels in mouse tissues by HPLC with coulometric detection. Clin Chim Acta 341, 173–184.PubMedCrossRefGoogle Scholar
  20. 20.
    Sacconi S., Trevisson E., Salviati L., et al. (2010) Coenzyme Q10 is frequently reduced in muscle of patients with mitochondrial myopathy. Neuromuscul Disord 20, 44–48.PubMedCrossRefGoogle Scholar
  21. 21.
    Tang P.H., Miles M.V., Steele P., et al. (2006) Determination of coenzyme Q10 in human breast milk by high-performance liquid chromatography. Biomed Chromatogr 20, 1336–1343.PubMedCrossRefGoogle Scholar
  22. 22.
    Colomé C., Artuch R., Vilaseca M.A. et al. (2002) Ubiquinone-10 content in lymphocytes of phenylketonuric patients. Clin Biochem 35, 81–84.PubMedCrossRefGoogle Scholar
  23. 23.
    Kohli R., Kirby M., Xanthakos S.A., et al. (2010) High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis. Hepatology 52, 934–944.PubMedCrossRefGoogle Scholar
  24. 24.
    Isobe C., Abe T., and Terayama Y. (2010) Levels of reduced and oxidized coenzyme Q-10 and 8-hydroxy-2′-deoxyguanosine in the cerebrospinal fluid of patients with living Parkinson’s disease demonstrate that mitochondrial oxidative damage and/or oxidative DNA damage contributes to the neurodegenerative process. Neurosci Lett 469, 159–163.PubMedCrossRefGoogle Scholar
  25. 25.
    Niklowitz P., Menke T., Wiesel T., et al. (2002) Coenzyme Q10 in plasma and erythrocytes: comparison of antioxidant levels in healthy probands after oral supplementation and in patients suffering from sickle cell anemia. Clin Chim Acta 326, 155–161.PubMedCrossRefGoogle Scholar
  26. 26.
    Albano C.B., Muralikrishnan D., and Ebadi M. (2002) Distribution of coenzyme Q homologues in brain. Neurochem Res 27, 359–368.PubMedCrossRefGoogle Scholar
  27. 27.
    Balercia G., Buldreghini E., Vignini A., et al. (2009) Coenzyme Q10 treatment in infertile men with idiopathic asthenozoospermia: a placebo-controlled, double-blind randomized trial. Fertil Steril 91, 1785–1792.PubMedCrossRefGoogle Scholar
  28. 28.
    Diomedi-Camassei F., Di Giandomenico S., Santorelli F.M., et al. (2007) COQ2 nephropathy: a newly described inherited mitochondriopathy with primary renal involvement. J Am Soc Nephrol 18, 2773–2780.PubMedCrossRefGoogle Scholar
  29. 29.
    Montero R., Sánchez-Alcázar J.A., Briones P., et al. (2008) Analysis of coenzyme Q10 in muscle and fibroblasts for the diagnosis of CoQ10 deficiency syndromes. Clin Biochem 41, 697–700.PubMedCrossRefGoogle Scholar
  30. 30.
    Haas D., Niklowitz P., Hörster F., et al. (2009) Coenzyme Q(10) is decreased in fibroblasts of patients with methylmalonic aciduria but not in mevalonic aciduria. J Inherit Metab Dis 32, 570–575.PubMedCrossRefGoogle Scholar
  31. 31.
    DiMauro S., Quinzii C.M., and Hirano M. (2007) Mutations in coenzyme Q10 biosynthetic genes. J Clin Invest 117, 587–589.PubMedCrossRefGoogle Scholar
  32. 32.
    Debray F.G., Lambert M., and Mitchell G.A. (2008) Disorders of mitochondrial function. Curr Opin Pediatr 20, 471–482.PubMedCrossRefGoogle Scholar
  33. 33.
    Miles M.V., Patterson B.J., Chalfonte–Evans M., et al. (2007) Ubiquinol-10 improves oxidative imbalance in children with trisomy 21. Pediatr Neurol 37, 398–403.Google Scholar
  34. 34.
    Montero R., Sánchez-Alcázar J.A., Briones P., et al. (2009) Coenzyme Q10 deficiency associated with a mitochondrial DNA depletion syndrome: a case report. Clin Biochem 42, 742–745.PubMedCrossRefGoogle Scholar
  35. 35.
    Haas D., Niklowitz P., Hoffmann G.F., et al. (2008) Plasma and thrombocyte levels of coenzyme Q10 in children with Smith-Lemli-Opitz syndrome (SLOS) and the influence of HMG-CoA reductase inhibitors. Biofactors 32, 191–197.PubMedCrossRefGoogle Scholar
  36. 36.
    Sohmiya M., Tanaka M., Tak N.W., et al. (2004) Redox status of plasma coenzyme Q10 indicates elevated systemic oxidative stress in Parkinson’s disease. J Neurol Sci 223, 161–166.PubMedCrossRefGoogle Scholar
  37. 37.
    Cooper J.M., Korlipara L.V., Hart P.E., et al. (2008) Coenzyme Q10 and vitamin E deficiency in Friedreich’s ataxia: predictor of efficacy of vitamin E and coenzyme Q10 therapy. Eur J Neurol 15, 1371–1379.PubMedCrossRefGoogle Scholar
  38. 38.
    Ochoa J.J., Ramirez-Tortosa M.C., Quiles J.L., et al. (2003) Oxidative stress in erythrocytes from premature and full-term infants during their first 72 h of life. Free Radic Res 3, 317–322.CrossRefGoogle Scholar
  39. 39.
    Roland L., Gagné A., Bélanger M.C., et al. (2010) Existence of compensatory defense mechanisms against oxidative stress and hypertension in preeclampsia. Hypertens Pregnancy 29, 21–37.PubMedCrossRefGoogle Scholar
  40. 40.
    Hershey A.D., Powers S.W., Vockell A.L., et al. (2007) Coenzyme Q10 deficiency and response to supplementation in pediatric and adolescent migraine. Headache 47, 73–80.PubMedCrossRefGoogle Scholar
  41. 41.
    Laguna T.A., Sontag M.K., Osberg I., et al. (2008) Decreased total serum coenzyme-Q10 concentrations: a longitudinal study in children with cystic fibrosis. J Pediatr 153, 402–407.PubMedCrossRefGoogle Scholar
  42. 42.
    Mancini A., Leone E., Silvestrini A., et al. (2010) Evaluation of antioxidant systems in pituitary-adrenal axis diseases. Pituitary 13, 138–145.PubMedCrossRefGoogle Scholar
  43. 43.
    Bélanger M.C., Mirault M.E., Dewailly E., et al. (2008) Environmental contaminants and redox status of coenzyme Q10 and vitamin E in Inuit from Nunavik. Metabolism 57, 927–933.PubMedCrossRefGoogle Scholar
  44. 44.
    Suzuki T., Nozawa T., Sobajima M., et al. (2008) Atorvastatin-induced changes in plasma coenzyme Q10 and brain natriuretic peptide in patients with coronary artery disease. Int Heart J 49, 423–433.PubMedCrossRefGoogle Scholar
  45. 45.
    Niklowitz P., Wiesel T., Andler W., and Menke T. (2007) Coenzyme Q10 concentration in the plasma of children suffering from acute lymphoblastic leukemia before and during induction treatment. Biofactors 29, 83–89.PubMedCrossRefGoogle Scholar
  46. 46.
    Steele P.E., Tang P.H., DeGrauw T.J., and Miles M.V. (2004) Clinical laboratory monitoring of coenzyme Q10 use in neurologic and muscular diseases. Am J Clin Pathol 121 (Suppl 1), S113–S120.PubMedGoogle Scholar
  47. 47.
    Takada M., Ikenoya S., Yuzuriha T., and Katayama K. (1984) Simultaneous determination of reduced and oxidized ubiquinones. Methods Enzymol 105, 147–155.PubMedCrossRefGoogle Scholar
  48. 48.
    Lang J.K. and Packer L. (1987) Quantitative determination of vitamin E and oxidized and reduced coenzyme Q by high-performance liquid chromatography with in-line ultraviolet and electrochemical detection. J Chromatogr 385, 109–117.PubMedCrossRefGoogle Scholar
  49. 49.
    Edlund P.O. (1988) Determination of coenzyme Q10, alpha-tocopherol and cholesterol in biological samples by coupled-column liquid chromatography with coulometric and ultraviolet detection. J Chromatogr 425, 87–97.PubMedCrossRefGoogle Scholar
  50. 50.
    Okamoto T., Fukunaga Y., Ida Y., and Kishi T. (1988) Determination of reduced and total ubiquinones in biological materials by liquid chromatography with electrochemical detection. J Chromatogr 430, 11–19.PubMedCrossRefGoogle Scholar
  51. 51.
    Grossi G., Bargossi A.M., Fiorella P.L., and Piazzi S. (1992) Improved high-performance liquid chromatographic method for the determination of coenzyme Q10 in plasma. J Chromatogr 593, 217–226.PubMedCrossRefGoogle Scholar
  52. 52.
    Wakabayashi H., Yamato S., Nakajima M., and Shimada K. (1994) Simultaneous determination of oxidized and reduced coenzyme Q and alpha-tocopherol in biological samples by high performance liquid chromatography with platinum catalyst reduction and electrochemical detection. Biol Pharm Bull 17, 997–1002.PubMedCrossRefGoogle Scholar
  53. 53.
    Finckh B., Kontush A., Commentz J., et al. (1995) Monitoring of ubiquinol-10, ubiquinone-10, carotenoids, and tocopherols in neonatal plasma microsamples using high-performance liquid chromatography with coulometric electrochemical detection. Anal Biochem 232, 210–216.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  1. 1.Division of Pathology and Laboratory MedicineCincinnati Children’s Hospital Medical CenterCincinnatiUSA
  2. 2.Division of Pathology and Laboratory Medicine, Departments of Pediatrics and Pathology & Laboratory MedicineCincinnati Children’s Hospital Medical Center and University of Cincinnati College of MedicineCincinnatiUSA

Personalised recommendations